Fibrosis is a key inhibitor of lymphatic regeneration

Plastic and Reconstructive Surgery

Volumn 124, Issue 2, 2009, Pages 438-450

  Avraham, Tomer ^a   Clavin, Nicholas W ^a   Daluvoy, Sanjay V ^a   Fernandez, John ^a   Soares, Marc A ^a   Cordeiro, Andrew P ^a   Mehrara, Babak J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; SCLEROPROTEIN; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL ANIMAL; EXTRACELLULAR MATRIX; FEMALE; GEL; GENE EXPRESSION; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHEDEMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SOFT TISSUE; TAIL; TISSUE SECTION; VASCULAR FIBROSIS; WOUND DRESSING; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; COLLAGEN TYPE I; ENDOTHELIAL CELLS; FEMALE; FIBROSIS; GELS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; LYMPHEDEMA; MICE; MICE, INBRED STRAINS; MODELS, ANIMAL; POLYMERASE CHAIN REACTION; REGENERATION; TAIL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; WOUND HEALING;

EID: 69249104250     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181adcf4b     Document Type: Article

References (34)

1. Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema: A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer 2002;95:2260-2267. (Pubitemid 35351130)
2. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177:184-187; discussion 188. (Pubitemid 29183869)
3. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: Risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405-411. (Pubitemid 39281312)
4. Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to postmastectomy radiation: Incidence and risk factors. Ann Surg Oncol. 2004;11:573-580. (Pubitemid 40486714)
5. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-999.
6. Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem. 2007;282:23337-23347. (Pubitemid 47311952)
7. Haviv YS, Takayama K, Nagi PA, et al. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded soluble type II TGF-beta receptor fusion molecule. J Gene Med. 2003;5:839-851. (Pubitemid 40310408)
8. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to- mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952-961. (Pubitemid 47222040)
9. Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007;127:1009-1017. (Pubitemid 46625163)
10. Clavin NW, Avraham T, Fernandez JG, et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol. 2008;295:H2113-H2127.
11. Mehrara BJ, Mackool RJ, McCarthy JG, Gittes GK, Longaker MT. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg. 1998;102:1805-1817; discussion 1818-1820.
12. Sitzia J. Volume measurement in lymphoedema treatment: Examination of formulae. Eur J Cancer Care 1995;4:11-16.
13. Tabibiazar R, Cheung L, Han J, et al. Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 2006;3:e254. (Pubitemid 44125997)
14. Schonmeyr BH, Wong AK, Soares M, Fernandez J, Clavin N, Mehrara BJ. Ionizing radiation of mesenchymal stem cells results in diminution of the precursor pool and limits potential for multilineage differentiation. Plast Reconstr Surg. 2008;122:64-76.
15. Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103:714-718. (Pubitemid 44602163)
16. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006;15:153-165. (Pubitemid 46241869)
17. Warren AG, Slavin SA. Scar lymphedema: Fact or fiction? Ann Plast Surg. 2007;59:41-45.
18. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286-1292. (Pubitemid 24333194)
19. Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199-210.
20. Kim KH, Kim HC, Hwang MY, et al. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Commun. 2006;343:1072-1078.
21. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18:816-827.
22. Andersson-Sjoland A, de Alba CG, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol. 2008;40:2129-2140.
23. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest. 2007;87:858-870. (Pubitemid 47267815)
24. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep. 2006;8:145-150.
25. Zhang X, Groopman JE, Wang JF. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J Cell Physiol. 2005;202:205-214.
26. Shin JW, Jurisic G, Detmar M. Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial function. Exp Cell Res. 2008;314:3048-3056.
27. Daroczy J. Pathology of lymphedema. Clin Dermatol. 1995; 13:433-444.
28. Talarico F, Brunetto D, Scialabba M, et al. Fibrosclerotic lymphedema: Pathophysiology and therapy. Lymphology 1991;24:11-15.
29. Suami H, Pan WR, Taylor GI. Changes in the lymph structure of the upper limb after axillary dissection: Radiographic and anatomical study in a human cadaver. Plast Reconstr Surg. 2007;120:982-991. (Pubitemid 47367896)
30. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776-1784. (Pubitemid 38063698)
31. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelialmesenchymal transition: New insights in signaling, development, and disease. J Cell Biol. 2006;172:973-981.
32. Teng Y, Zeisberg M, Kalluri R. Transcriptional regulation of epithelial- mesenchymal transition. J Clin Invest. 2007;117:304-306. (Pubitemid 46203957)
33. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelialmesenchymal transdifferentiation: In vitro analysis. Circ Res. 2002;90:1189-1196.
34. Deissler H, Deissler H, Lang GK, Lang GE. TGFbeta induces transdifferentiation of iBREC to alphaSMA-expressing cells. Int J Mol Med. 2006;18:577-582.